TipRanks
BrightPath Biotherapeutics Co.Ltd. (JP:4594)
:4594
Japanese Market
4594
BrightPath Biotherapeutics Co.Ltd.
RESEARCH TOOLSreports
Want to see JP:4594 full AI Analyst Report?

BrightPath Biotherapeutics Co.Ltd. (4594) Ratios

0 Followers

BrightPath Biotherapeutics Co.Ltd. Ratios

JP:4594's free cash flow for Q4 2025 was ¥0.59. For the 2025 fiscal year, JP:4594's free cash flow was decreased by ¥ and operating cash flow was ¥-6.85K. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 15.56 15.83 8.14 6.18 21.57
Quick Ratio
 15.56 15.83 8.14 6.18 21.57
Cash Ratio
 12.46 13.36 6.16 5.54 20.00
Solvency Ratio
 -7.89 -5.52 -5.88 -4.65 -10.97
Operating Cash Flow Ratio
 0.00 -8.46 -9.50 -6.06 -15.73
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -50.01 -10.28 0.00
Net Current Asset Value
¥ 1.77B¥ 2.32B¥ 875.69M¥ 929.69M¥ 1.52B
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.02 0.09 0.00
Debt-to-Equity Ratio
 0.00 0.00 0.03 0.11 0.00
Debt-to-Capital Ratio
 0.00 0.00 0.03 0.10 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.11 1.10 1.21 1.26 1.09
Debt Service Coverage Ratio
 0.00 0.00 -46.05 -10.25 -24.08K
Interest Coverage Ratio
 0.00 0.00 0.00 -825.65 -24.05K
Debt to Market Cap
 0.00 0.00 <0.01 0.03 0.00
Interest Debt Per Share
 0.00 0.00 0.31 1.78 <0.01
Net Debt to EBITDA
 0.98 1.66 0.68 0.81 1.04
Profitability Margins
Gross Profit Margin
62.90%65.48%97.18%-473.61%64.11%
EBIT Margin
-2594083.87%-1550632.14%-101434.16%-1619697.22%-28099.85%
EBITDA Margin
-2594083.87%-1550632.14%-101434.16%-1619147.22%-27783.18%
Operating Profit Margin
-2575346.77%-1541666.67%-102464.08%-1604276.39%-27785.21%
Pretax Profit Margin
-2566537.10%-1550632.14%-101434.16%-1619697.22%-28101.00%
Net Profit Margin
-2570440.32%-1553513.10%-101601.85%-1622336.11%-28136.99%
Continuous Operations Profit Margin
-2570440.32%-1553513.10%-101601.85%-1622336.11%-28136.99%
Net Income Per EBT
100.15%100.19%100.17%100.16%100.13%
EBT Per EBIT
99.66%100.58%98.99%100.96%101.14%
Return on Assets (ROA)
-78.72%-50.10%-102.73%-94.95%-87.32%
Return on Equity (ROE)
-93.35%-55.10%-124.45%-119.32%-94.77%
Return on Capital Employed (ROCE)
-84.14%-53.00%-117.39%-111.15%-90.29%
Return on Invested Capital (ROIC)
-84.14%-53.00%-114.49%-100.29%-90.29%
Return on Tangible Assets
-78.72%-50.10%-102.73%-94.95%-87.32%
Earnings Yield
-18.81%-16.95%-32.10%-27.58%-14.48%
Efficiency Ratios
Receivables Turnover
 5.17 <0.01 0.02 12.00 96.00
Payables Turnover
 7.67 0.91 0.91 20.65 24.61
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 <0.01 <0.01 <0.01 <0.01 <0.01
Working Capital Turnover Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Cash Conversion Cycle
 23.04 220.56K 20.44K 12.74 -11.03
Days of Sales Outstanding
 70.65 220.96K 20.84K 30.42 3.80
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 47.61 402.76 399.22 17.68 14.83
Operating Cycle
 70.65 220.96K 20.84K 30.42 3.80
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 -12.24 -15.34 -18.03 -20.19
Free Cash Flow Per Share
 0.00 -12.25 -15.36 -18.15 -20.22
CapEx Per Share
 0.00 <0.01 0.02 0.12 0.03
Free Cash Flow to Operating Cash Flow
 0.00 1.00 1.00 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 -2.31K -912.67 -151.27 -684.32
Capital Expenditure Coverage Ratio
 0.00 -2.31K -912.67 -151.27 -684.32
Operating Cash Flow Coverage Ratio
 0.00 0.00 -50.01 -10.28 0.00
Operating Cash Flow to Sales Ratio
 0.00 -16.26K -1.10K -16.07K -228.11
Free Cash Flow Yield
0.00%-17.75%-34.90%-27.50%-11.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -4.77 -5.90 -3.12 -3.63 -6.91
Price-to-Sales (P/S) Ratio
 82.65K 91.64K 3.17K 58.82K 1.94K
Price-to-Book (P/B) Ratio
 4.65 3.25 3.88 4.33 6.55
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 -5.63 -2.87 -3.64 -8.51
Price-to-Operating Cash Flow Ratio
 0.00 -5.64 -2.87 -3.66 -8.52
Price-to-Earnings Growth (PEG) Ratio
 0.55 0.34 0.14 0.13 0.54
Price-to-Fair Value
 4.65 3.25 3.88 4.33 6.55
Enterprise Value Multiple
 -2.20 -4.25 -2.44 -2.82 -5.95
Enterprise Value
 3.54B 5.54B 2.80B 3.29B 8.73B
EV to EBITDA
 -2.20 -4.25 -2.44 -2.82 -5.95
EV to Sales
 57.15K 65.97K 2.47K 45.69K 1.65K
EV to Free Cash Flow
 0.00 -4.06 -2.24 -2.82 -7.24
EV to Operating Cash Flow
 0.00 -4.06 -2.24 -2.84 -7.25
Tangible Book Value Per Share
 13.12 21.23 11.35 15.26 26.27
Shareholders’ Equity Per Share
 13.12 21.23 11.35 15.26 26.27
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 <0.01 <0.01 0.01 <0.01 0.09
Net Income Per Share
 -11.47 -11.70 -14.12 -18.21 -24.90
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.99 1.00 1.00 1.00 1.00
Research & Development to Revenue
 0.00 0.00 783.82 0.00 221.30
SG&A to Revenue
 25.75K 15.42K 241.80 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 1.05 1.09 0.99 0.81
Currency in JPY